Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Amortizatization of Intangibles (2017 - 2025)

Historic Amortizatization of Intangibles for Avalo Therapeutics (AVTX) over the last 7 years, with Q3 2025 value amounting to $347000.0.

  • Avalo Therapeutics' Amortizatization of Intangibles changed N/A to $347000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $347000.0, marking a year-over-year change of. This contributed to the annual value of $1.8 million for FY2023, which is 3160.55% up from last year.
  • According to the latest figures from Q3 2025, Avalo Therapeutics' Amortizatization of Intangibles is $347000.0.
  • Avalo Therapeutics' 5-year Amortizatization of Intangibles high stood at $1.1 million for Q3 2023, and its period low was $104000.0 during Q2 2021.
  • In the last 4 years, Avalo Therapeutics' Amortizatization of Intangibles had a median value of $349000.0 in 2021 and averaged $396181.8.
  • Examining YoY changes over the last 5 years, Avalo Therapeutics' Amortizatization of Intangibles showed a top increase of 22307.69% in 2022 and a maximum decrease of 0.0% in 2022.
  • Over the past 4 years, Avalo Therapeutics' Amortizatization of Intangibles (Quarter) stood at $349000.0 in 2021, then changed by 0.0% to $349000.0 in 2022, then soared by 223.5% to $1.1 million in 2023, then crashed by 69.26% to $347000.0 in 2025.
  • Its last three reported values are $347000.0 in Q3 2025, $1.1 million for Q3 2023, and $349000.0 during Q2 2023.